Exicure, Inc., an early-stage biotechnology company, has announced the signing of a Memorandum of Understanding (MoU) with GPCR Therapeutics, Inc., a clinical-stage international biopharmaceutical ...

Chugai Pharmaceutical Co., Ltd. announced that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for “Lunsumio for intravenous infusion 1mg” and “Lunsumio for ...